ECG Telemetry Device - Market Insights, Competitive Landscape, and Market Forecast - 2032

ECG Telemetry Devices Market by Product Type (Resting ECG Device, Stress ECG Device, and Others), Type (Wired and Wireless), Application (Arrhythmias, Myocardial Ischemia, and Others), End-User (Homecare Settings, Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2032 owing to the increasing prevalence of cardiovascular disorders and the rising product developmental activities worldwide.

The ECG telemetry devices market is estimated to grow at a CAGR of 7.29% during the forecast period from 2025 to 2032. The ECG telemetry devices market is witnessing growth due to the rising prevalence of chronic conditions such as cardiovascular diseases, particularly atrial fibrillation. This growth is further supported by increasing product development initiatives, a surge in risk factors linked to sedentary lifestyles, a rapidly aging population, and other factors that are expected to significantly propel the ECG telemetry devices market expansion during the forecast period from 2025 to 2032.

ECG Telemetry Devices Market Dynamics:

As per recent data provided by the British Heart Foundation (2025), currently around 7.6 million people are affected by heart or circulatory disease. The same source also stated that around 2.3 million people were living with coronary heart disease. Further, according to recent data provided by the American Heart Association (2023), it was estimated that by 2030, over 12 million people will have atrial fibrillation globally. Hence, the rising prevalence of cardiovascular diseases and arrhythmias is accelerating the adoption of ECG telemetry devices. These systems enable real-time, remote monitoring of cardiac activity, allowing for earlier diagnosis, immediate detection of abnormal heart rhythms, and rapid medical intervention, thereby boosting the overall market of ECG telemetry devices.

Increased product development activities among market key players across the globe are slated to witness market growth for the ECG telemetry devices. For example, in April 2022, Google announced that Fitbit received FDA clearance for its photoplethysmography (PPG) algorithm designed to detect atrial fibrillation. This algorithm will support Fitbit’s newly introduced irregular heart rhythm notification feature.

As per data provided by the World Health Organization 2024, it stated that by 2030, 1 in 6 people will age 60 years or above, and by the year 2050, the global population of individuals aged 60 and above was projected to double, reaching 2.1 billion. Meanwhile, the number of people aged 80 and older was expected to triple between 2020 and 2050, rising to 426 million. Since older adults are more prone to cardiovascular disorders such as arrhythmias, atrial fibrillation, and heart failure, the need for continuous, real-time cardiac monitoring becomes critical. This demographic shift is significantly driving the adoption of ECG telemetry devices, as they offer efficient, non-invasive solutions for early detection and management of heart-related conditions in elderly patients.

However, the increase in product development activities among the key market players is further propelling the market growth. For instance, in March 2022, ZOLL® Medical Corporation announced the launch of the ZOLL Arrhythmia Management System (AMS). This advanced system enhances traditional cardiac telemetry by integrating biometric data, such as heart rate, activity level, respiratory rate, and body posture, alongside standard ECG monitoring.

Hence, the interplay of all the above-mentioned factors is expected to drive the market for ECG telemetry devices market during the given forecast period from 2025 to 2032.

However, the technological limitations associated with these devices, data security and privacy concerns, among others, may restrict the market growth of the ECG telemetry devices.

ECG Telemetry Devices Market Segment Analysis:

ECG Telemetry Devices Market by Product Type (Resting ECG Device, Stress ECG Device, and others), Type (Wired and Wireless), Application (Arrhythmias, Myocardial Ischemia, and Others), End-User (Homecare Settings, Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the type segment of the ECG telemetry devices market, the wireless category is expected to have a significant revenue share in the year 2024. This is due to the range of technological advancements and clinical benefits. Wireless ECG telemetry eliminates cumbersome cables, allowing patients to move freely while still being continuously monitored.

In addition to this, wireless devices support real-time data transmission through Bluetooth or cellular connectivity, enabling healthcare providers to receive immediate updates and respond promptly to cardiac irregularities such as arrhythmias or atrial fibrillation. Their compact, lightweight, and wearable design further improves patient compliance during extended monitoring periods. For instance, the iRhythm Zio Patch is a widely used wireless ECG monitoring device that offers up to 14 days of continuous, unobtrusive monitoring, with data securely transmitted for clinical evaluation.

Moreover, these devices often integrate seamlessly with cloud-based platforms, allowing clinicians remote access to patient data, which enhances diagnostic efficiency and supports the growing trend of telehealth. The cable-free design also reduces the risk of skin irritation and infections while minimizing maintenance requirements. Further, the increasing planned activities by the key players, such as product launches, will also drive the market of wireless-ECG telemetry devices. For instance, in 2022, Apple launched the wireless Apple Watch Series 8 and the new Apple Watch SE for continuous ECG recording.

Therefore, the widespread use and various advantages of wireless enhance performance and usability, solidifying the significant impact on the growth of the overall ECG telemetry devices market during the forecast period from 2025 to 2032.

North America is expected to dominate the overall ECG telemetry devices market:

Among all the regions, North America is estimated to hold a significant revenue share in the ECG telemetry devices market in 2024. This can be attributed to the high incidence of myocardial infarctions and other cardiovascular conditions, along with a growing its associated risk factors such as hypertension, diabetes, and obesity. Moreover, continuous advancements in product development, increasing regulatory approvals, and the presence of a robust and well-established healthcare infrastructure are playing a pivotal role in driving market expansion across the region during the forecast period from 2025 to 2032.

According to data from the Centers for Disease Control and Prevention (2024), it was stated that 805,000 people in the US have a myocardial infarction (heart attack) every year on average. Also, as per the same source, it was stated that heart disease is an umbrella term that encompasses numerous conditions such as acute coronary syndrome, atherosclerosis, and congestive heart failure, among others. Some of the key risk factors associated with heart disease are high blood cholesterol, high blood pressure, and smoking. The source further mentioned that about half of the Americans (47%) have at least one of these three risk factors.

According to data from the Canadian Institute for Health Information (2024), it stated that in 2022, 2.4 million Canadians were affected by heart disease.

Thus growing prevalence of heart disease and its associated risk factors highlights the urgent need for advanced diagnostic and monitoring technologies. ECG telemetry devices play a crucial role by providing real-time cardiac monitoring, facilitating early detection, and enhancing patient outcomes. As the global burden of cardiovascular conditions continues to rise, these devices are becoming essential tools in effective disease management and healthcare delivery.

Rising product development activities by regulatory bodies in the region will further boost the market for ECG telemetry devices. For example, in April 2022, Biotricity, a medical diagnostic and healthcare technology player, launched the commercial sales of the Biotres, an FDA-approved wireless wearable extended Holter monitor, a type of ECG telemetry devices for up to 30-day wear duration.

Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the ECG telemetry devices market during the forecast period from 2025 to 2032.

ECG Telemetry Devices Market key players:

Some of the key market players operating in the ECG telemetry devices market include NIHON KOHDEN CORPORATION, Baxter, Boston Scientific Corporation, GE HealthCare, Koninklijke Philips N.V., iRhythm Technologies, Inc., Aerotel Medical Systems Ltd, Medtronic, Mindray Medical India Pvt. Ltd., Medicalgorithmics, Scottcare cardiovascular solution, ZOLL Medical Corporation, CONTEC MEDICAL SYSTEMS CO., LTD., Monarch Meditech, Perlong Medical Equipment Co., Ltd., and others.

Recent Developmental Activities in the ECG Telemetry Devices Market:

• In November 2024, SmartCardia received FDA clearance for its Mobile Outpatient Cardiac Telemetry (OCT/MCT) system, featuring a 7-lead live ECG monitoring patch integrated with a cloud-based platform.
• In October 2024, iRhythm Technologies, Inc., a prominent digital healthcare company dedicated to developing reliable solutions for the detection, prediction, and prevention of disease, announced that the U.S. Food and Drug Administration (FDA) granted clearance for its 510(k) submission concerning design modifications and labeling updates for the Zio AT a cardiac telemetry device.
• In March 2023, iRhythm Technologies announced findings supporting its Zio XT wearable heart monitoring technology. The study concluded that Zio XT demonstrated the lowest likelihood of retesting compared to all other ambulatory cardiac monitors (ACMs). It also recorded the lowest acute healthcare resource utilization compared to all other ACMs.
• In January 2022, Philips introduced the First At-home, 12-lead ECG Integrated Solution for decentralized clinical trials.

Key takeaways from the ECG telemetry devices market report study

• Market size analysis for the current ECG telemetry devices market size (2024), and market forecast over 8 years (2025 to 2032)
• Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the ECG telemetry devices market
• Various opportunities available for other competitors in the ECG telemetry devices market space
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current ECG telemetry devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for the ECG telemetry devices market growth in the future?

Target audience who can benefit from this ECG telemetry devices market report study

• ECG telemetry devices providers
• Research organizations and consulting companies
• ECG telemetry devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in ECG telemetry devices
• Various end-users who want to know more about the ECG telemetry devices market and the latest developments in the ECG telemetry devices market

Frequently Asked Questions for the ECG Telemetry Devices Market:

1. What is an ECG telemetry devices?

• The ECG telemetry devices are devices used in the monitoring of the electrical activities of the heart. It is a portable device that continuously monitors a patient’s ECG, respiratory rate, and oxygen saturation while automatically transmitting information to a central monitor.

2. What is the market for the ECG telemetry devices?

• The ECG telemetry devices market is estimated to grow at a CAGR of 7.29% during the forecast period from 2025 to 2032.

3. What are the drivers for the ECG telemetry devices market?

• The ECG telemetry devices market is witnessing substantial growth due to the rising prevalence of chronic conditions such as cardiovascular diseases, particularly atrial fibrillation. This growth is further supported by increasing product development initiatives, a surge in risk factors linked to sedentary lifestyles, a rapidly aging population, and other factors that are expected to significantly propel the ECG telemetry devices market expansion during the forecast period from 2025 to 2032.

4. Who are the key players operating in the ECG telemetry devices market?

• Some of the major market players operating in the ECG telemetry devices market include NIHON KOHDEN CORPORATION, Baxter, Boston Scientific Corporation, GE HealthCare, Koninklijke Philips N.V., iRhythm Technologies, Inc., Aerotel Medical Systems Ltd, Medtronic, Mindray Medical India Pvt. Ltd., Medicalgorithmics, Scottcare cardiovascular solution, ZOLL Medical Corporation, CONTEC MEDICAL SYSTEMS CO., LTD., Monarch Meditech, Perlong Medical Equipment Co., Ltd., and others.

5. Which region has the highest share in the ECG telemetry devices market?

• Among all the regions, North America is estimated to hold a significant revenue share in the ECG telemetry devices market in 2024. This can be attributed to the high incidence of myocardial infarctions and other cardiovascular conditions, along with a growing its associated risk factors such as hypertension, diabetes, and obesity. Moreover, continuous advancements in product development, increasing regulatory approvals, and the presence of a robust and well-established healthcare infrastructure are playing a pivotal role in driving market expansion across the region during the forecast period from 2025 to 2032.

This product will be delivered within 2 business days.